No Data
No Data
H.C. Wainwright Maintains BioAtla(BCAB.US) With Hold Rating
Citizens Capital Markets Maintains Market Outperform on BioAtla, Lowers Price Target to $1
Express News | HC Wainwright & Co. Reiterates Neutral on BioAtlato Neutral
BioAtla Analyst Ratings
JMP Securities Maintains BioAtla(BCAB.US) With Buy Rating, Cuts Target Price to $1
Companies Like BioAtla (NASDAQ:BCAB) Could Be Quite Risky